EISSN 2148-5607

TJG IS INDEXED IN SCI-EXPANDED AND PUBMED IMPACT FACTOR: 1.4

Turkish Journal of Gastroenterology

35 414 2024

Submission to First Decision = 31 Days

HIGHLY CITED ARTICLES

HBV and HCV are the risk factors in CCA

Tan et al.

Serum resolvin levels in irritable bowel syndrome

Karatay and Gül Utku

Microbial improvement after intervention

Qian et al.

18F-FDGPET/CT in gallbladder carcinoma

Arslan et al.

Bezoar in endoscopy

Gökbulut et al.

Effect of vitamin D on CD40L gene expression in UC

Sharifi et al.

ERCP for acute cholangitis

Khamaysi and Taha

Inborn metabolic causes of fatty liver disease

Yıldız and Sivri

Gastric and small intestinal TSA

Kiremitci et al.

COVID-19 in Hepatology and Liver transplantation

Kabaçam et al.

Author’s Response

RE: Could Hepatitis B Reactivation Be Overlooked in Patients with Resolved HBV Infection and Receiving Immunosuppressive Treatment?

Pingyang Han ^{1 2} , Ziqiu Wang ^{1 3} , Zhaohui Wang ¹

Author Affiliation(s)

1.

Department of Nephrology, Ruijin Hospital, Shanghai Jiao Tong University Faculty of Medicine, Shanghai, China

2.

Department of Nephrology, The Affiliated Hospital of Hangzhou Normal University, Hangzhou, Zhejiang Province, China

3.

Department of Clinical Medicine, Shanghai Jiao Tong University Faculty of Medicine, Shanghai, China

Turk J Gastroenterol 2024; 35: 352-353

DOI: 10.5152/tjg.2024.235342

Read: 554 Downloads: 176 Published: 31 March 2024

Volume 35, Issue 4, April 2024

Previous Article

Cite this article as: Han P, Wang Z, Wang Z. RE: Could hepatitis B reactivation be overlooked in patients with resolved HBV infection and receiving immunosuppressive treatment? Turk J Gastroenterol. 2024;35(4):352-353.

Files